The North America Laboratory Equipment Services Market is witnessing robust growth, driven by increased investments in R&D among pharmaceutical and biotechnology sectors, and a growing focus on advanced healthcare infrastructure. The market, valued at USD 5,200 million in 2025, is expected to reach USD 10,890 million by 2035, reflecting a CAGR of 7.1% from 2024 to 2035. The industry is being shaped by digital transformation, expansion in contract service offerings, and the emergence of integrated service models.
The economic impact of tariffs on "North America Laboratory Equipment Services Market".
Market Growth Drivers
Expanding Pharmaceutical and Biotechnology R&D: North America continues to lead in pharmaceutical innovation, with companies such as Thermo Fisher Scientific and Agilent Technologies ramping up investments in laboratory equipment. The surge in research activity—accelerated by precision medicine, biologics, and vaccine development—necessitates regular maintenance, calibration, and repair services for complex laboratory instruments. As a result, service providers are witnessing increased demand for both on-site and third-party maintenance contracts, ensuring optimal uptime and regulatory compliance across laboratory assets.
Growing Adoption of Outsourced Laboratory Services: Outsourcing laboratory equipment services has become increasingly prevalent among hospitals, academic medical centers, and independent labs seeking to reduce operational costs and complexities. Companies like Danaher Corporation and PerkinElmer are expanding their service networks to offer flexible, customizable service contracts, thereby helping end-users focus on core research. This trend is strengthened by the continual rise in laboratory automation and digital workflows, which require specialized, ongoing technical support to maximize productivity and extend equipment longevity.
Market Trends
Increasing Digitalization and Remote Monitoring: The industry is witnessing a shift towards remote equipment monitoring and predictive maintenance, enabled by IoT and cloud-based platforms. Firms such as Agilent Technologies are investing in connected service solutions that provide real-time equipment performance data, automate troubleshooting, and enable predictive analytics for maintenance scheduling. This digitalization dramatically reduces unplanned downtime, enhances laboratory efficiency, and provides data-driven insights into asset utilization, contributing to higher customer satisfaction and competitive differentiation.
Expansion of Integrated Service Offerings: Service providers are expanding their portfolios to include not only equipment repair and calibration but also training, validation, compliance consulting, and asset management. For example, Thermo Fisher Scientific has introduced comprehensive lifecycle management packages aimed at supporting laboratories through regulatory audits and quality initiatives. These integrated offerings help laboratories reduce vendor management complexity, ensure regulatory compliance, and streamline processes, aligning with evolving customer expectations.
Market Opportunities
Emergence of Advanced Diagnostic Labs: The proliferation of specialty diagnostic and research labs across North America creates substantial demand for specialized equipment services. Companies like Siemens Healthineers are positioned to capture new business through tailored service agreements for high-throughput, automated laboratory environments.
Rise of Genomics and Personalized Medicine: The rapid advancement in genomics and personalized medicine is driving demand for next-generation sequencing (NGS) and related technology support. Service providers such as Beckman Coulter are expanding their expertise in supporting the unique requirements of genomic laboratories, creating new revenue streams.
The market revenue chart illustrates steady and strong growth in the North America Laboratory Equipment Services Market over the 2020 to 2035 period. Beginning at approximately USD 3,400 million in 2020, the market experiences accelerated growth from 2024 onwards, reaching USD 5,200 million in 2025 and more than doubling to USD 10,890 million by 2035. This upward trend reflects increased investments in R&D, more complex laboratory infrastructure requiring specialized services, and a significant rise in outsourced service contracts. The compound annual growth rate (CAGR) is 7.1%, indicating sustained demand for laboratory equipment services as technology adoption and compliance needs escalate across diverse end-user segments.
Market Share by Region (%), 2025
The pie chart of North America Laboratory Equipment Services Market regional share for 2025 shows that the United States leads the market with a 74% share, reflecting its dominant presence in biomedical research, academic institutions, and pharmaceutical R&D. Canada holds a 15% share, benefitting from strong government funding and growing biotech clusters. Mexico accounts for 6%, with increasing investment in healthcare and contract research organizations. The remaining 5% is shared among other regions, including Puerto Rico and select Caribbean nations, indicating smaller but growing opportunities in these markets. These insights underscore the high concentration of market activity in the US, while highlighting notable expansion in other North American regions.
Recent Developments
In March 2024, Thermo Fisher Scientific launched a new remote diagnostic and predictive maintenance platform for laboratory instruments, reducing downtime by up to 30%. This AI-driven solution enables labs to schedule maintenance proactively, optimizing operational efficiency and asset longevity across pharma and biotech research centers.
In April 2024, Agilent Technologies announced the expansion of its service network in North America, adding five new regional service centers and introducing digital asset management dashboards for customers. The move strengthens Agilent’s commitment to rapid response times, improved parts availability, and enhanced customer experience throughout the US and Canada.
In May 2024, Danaher Corporation’s Beckman Coulter Life Sciences division revealed a strategic partnership with a major pharmaceutical group to provide end-to-end service solutions—including validation, compliance support, and user training—for new automated genomic analysis systems. This collaboration will deliver streamlined lab operations and regulatory compliance support to the partner’s North American sites.
Press Releases